Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial

Morag C Farquhar, A Toby Prevost, Paul McCrone, Barbara Brafman-Price, Allison Bentley, Irene J Higginson, Chris Todd, Sara Booth, Morag C Farquhar, A Toby Prevost, Paul McCrone, Barbara Brafman-Price, Allison Bentley, Irene J Higginson, Chris Todd, Sara Booth

Abstract

Background: Breathlessness is common in advanced cancer. The Breathlessness Intervention Service (BIS) is a multi-disciplinary complex intervention theoretically underpinned by a palliative care approach, utilising evidence-based non-pharmacological and pharmacological interventions to support patients with advanced disease. We sought to establish whether BIS was more effective, and cost-effective, for patients with advanced cancer and their carers than standard care.

Methods: A single-centre Phase III fast-track single-blind mixed-method randomised controlled trial (RCT) of BIS versus standard care was conducted. Participants were randomised to one of two groups (randomly permuted blocks). A total of 67 patients referred to BIS were randomised (intervention arm n = 35; control arm n = 32 received BIS after a two-week wait); 54 completed to the key outcome measurement. The primary outcome measure was a 0 to 10 numerical rating scale for patient distress due to breathlessness at two-weeks. Secondary outcomes were evaluated using the Chronic Respiratory Questionnaire, Hospital Anxiety and Depression Scale, Client Services Receipt Inventory, EQ-5D and topic-guided interviews.

Results: BIS reduced patient distress due to breathlessness (primary outcome: -1.29; 95% CI -2.57 to -0.005; P = 0.049) significantly more than the control group; 94% of respondents reported a positive impact (51/53). BIS reduced fear and worry, and increased confidence in managing breathlessness. Patients and carers consistently identified specific and repeatable aspects of the BIS model and interventions that helped. How interventions were delivered was important. BIS legitimised breathlessness and increased knowledge whilst making patients and carers feel 'not alone'. BIS had a 66% likelihood of better outcomes in terms of reduced distress due to breathlessness at lower health/social care costs than standard care (81% with informal care costs included).

Conclusions: BIS appears to be more effective and cost-effective in advanced cancer than standard care.

Trial registration: RCT registration at ClinicalTrials.gov NCT00678405 (May 2008) and Current Controlled Trials ISRCTN04119516 (December 2008).

Figures

Figure 1
Figure 1
CONSORT flow diagram.

References

    1. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care. 2003;1:337–344. doi: 10.1017/S1478951503030499.
    1. Thomas S, Bausewein C, Booth S. Breathlessness in cancer patients – implications, management and challenges. Eur J Oncol Nurs. 2011;15:459–469. doi: 10.1016/j.ejon.2010.11.013.
    1. Henoch I, Bergman B, Gustafsson M, Gaston-Johansson F, Danielson E. Dyspnea experience in patients with lung cancer in palliative care. Eur J Oncol Nurs. 2008;12:86–96. doi: 10.1016/j.ejon.2007.09.006.
    1. Corner J, Plant H, A’Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med. 1996;10:299–305. doi: 10.1177/026921639601000405.
    1. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318:901–904. doi: 10.1136/bmj.318.7188.901.
    1. Hately J, Laurence V, Scott A, Baker R, Thomas P. Breathlessness clinics within specialist palliative care settings can improve quality of life and functional capacity in patients with cancer. Palliat Med. 2003;17:410–417. doi: 10.1191/0269216303pm752oa.
    1. Booth S, Bausewein C, Rocker G. New models of care for advanced lung disease. Prog Palliat Care. 2011;19:254–263. doi: 10.1179/1743291X11Y.0000000016.
    1. Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RK, Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care The management of dyspnea in cancer patients: a systematic review. Support Care Cancer. 2008;16:329–337. doi: 10.1007/s00520-007-0389-6.
    1. Mahler DA. Understanding mechanisms and documenting plausibility of palliative interventions for dyspnea. Curr Opin Support Palliat Care. 2011;5:71–76. doi: 10.1097/SPC.0b013e328345bc84.
    1. Booth S, Moosavi SH, Higginson IJ. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nat Clin Pract Oncol. 2008;5:90–100. doi: 10.1038/ncponc1034.
    1. Gallo-Silver L, Pollack B. Behavioral interventions for lung cancer-related breathlessness. Cancer Pract. 2000;8:268–273. doi: 10.1046/j.1523-5394.2000.86005.x.
    1. Zhao I, Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med. 2008;22:693–701. doi: 10.1177/0269216308095024.
    1. Booth S, Moffatt C, Burkin J, Galbraith S, Bausewein C. Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011;5:77–86. doi: 10.1097/SPC.0b013e3283460c93.
    1. Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol. 2008;26:2396–2404. doi: 10.1200/JCO.2007.15.5796.
    1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA, Meek PM, O'Donnell DE, American Thoracic Society Committee on Dyspnea An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–452. doi: 10.1164/rccm.201111-2042ST.
    1. Booth S, Moffat C, Farquhar M, Higginson IJ, Burkin J. Developing a breathlessness service for patients with palliative and supportive care needs, irrespective of diagnosis. J Palliat Care. 2011;27:28–36.
    1. Booth S, Moffat C, Burkin J. The Cambridge BIS Manual – Building a Breathlessness Intervention Service. Cambridge: Cambridge University Hospitals NHS Foundation Trust; 2012.
    1. Breathlessness Intervention Service [] Accessed: 24 August 2014.
    1. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative Phase I study. Palliat Support Care. 2006;4:287–293. doi: 10.1017/S1478951506060366.
    1. Farquhar M, Higginson IJ, Fagan P, Booth S. The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. BMC Palliat Care. 2009;8:9. doi: 10.1186/1472-684X-8-9.
    1. Farquhar M, Higginson IJ, Fagan P, Booth S. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report. Palliat Support Care. 2010;8:143–149. doi: 10.1017/S1478951509990897.
    1. Farquhar M, Ewing G, Booth S. Using mixed-methods to develop and evaluate complex interventions in palliative care research. Palliat Med. 2011;25:748–757. doi: 10.1177/0269216311417919.
    1. Medical Research Council: A Framework for Development and Evaluation of RCTs for Complex Interventions to Improve Health. London; 2000.
    1. Farquhar M, Prevost AT, McCrone P, Higginson IJ, Gray J, Brafman-Kennedy B, Booth S. Study protocol: Phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. Trials. 2011;12:130. doi: 10.1186/1745-6215-12-130.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778. doi: 10.1136/thx.42.10.773.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Group EQL. EuroQoL-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Beecham J, Knapp M: Costing psychiatric interventions. In Measuring Mental Health Needs. 2nd edition. Edited by Thornicroft G. London: The Royal College of Psychiatrists; 2001:200–224.
    1. Curtis L. Unit Costs of Health and Social Care. Canterbury: PSSRU; 2012.
    1. Office for National Statistics: Annual Survey of Hours and Earnings, 2012 Provisional Results. 2012. . Accessed: 20 August 2014.
    1. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2007.
    1. Patton MQ: Qualitative Evaluation and Research Methods. 2nd edition. Newbury Park: CA, Sage Publications; 1990.
    1. NVivo 10 for Windows [] [Accessed: 21 June 2013]
    1. Ritchie J, Spencer L: Qualitative data analysis for applied policy research. In Analyzing Qualitative Data. Edited by Bryman A, Burgess RG. London: Routledge; 1994:173–194.
    1. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001;40:429–434. doi: 10.1348/014466501163904.
    1. Booth S. Science supporting the art of medicine: improving the management of breathlessness. Palliat Med. 2013;27:483–485. doi: 10.1177/0269216313488490.
    1. Lewin S, Glenton C, Oxman AD. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ. 2009;339:b3496. doi: 10.1136/bmj.b3496.
    1. Wood H, Connors S, Dogan S, Peel T. Individual experiences and impacts of a physiotherapist-led, non-pharmacological breathlessness programme for patients with intrathoracic malignancy: a qualitative study. Palliat Med. 2013;27:499–507. doi: 10.1177/0269216312464093.
    1. Ellis J, Wagland R, Tishelman C, Williams ML, Bailey CD, Haines J, Caress A, Lorigan P, Smith JA, Booton R, Blackhall F, Molassiotis A. Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers. J Pain Symptom Manage. 2012;44:831–842. doi: 10.1016/j.jpainsymman.2011.12.274.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다